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Thyroid gland is an easily approachable for direct examination by aspiration bi­
opsy organ. This fact gives a possibility for serial examination of liable disturbances in the 
immune regulation, connected with autoimmune thyroid disease and their response to the 
relevant therapy. Twenty-six patients with Basedow's disease (BD) and 12 patients with 
Hashimoto's thyroiditis (HT) - 34 women and 4 men (mean age 47,3 years) were studied. 
For determination of superficial markers of intrathyroidal mononuclear cells (ITMC) were 
used monoclonal antibodies for identification of total T-lymphocytes (CD3+), Т-helper/ 
inducer cells (CD4+), T-suppressor/cytotoxic eels (CD8+), B-lymphocytes (CD 19+), NK-
lymphocytes (CD16+56+), activated Т-lymphocytes (CD3+/HLA-DR+), interleukin-2 re­
ceptors (CD 25+), and the adhesion molecule ICAM-1 (CD54+). In the patients with BD 
the main lymphocyte subset was CD3+ with increased number of activated T-lymphocytes 
and CD4/CD8 ratio (2,22) due to the decreased number of T-suppressor/cytotoxic cells. 
After the thyreostatic therapy there was a normalization of B-lymphocytes, activated T-
lymphocytes and reduction of CD4/CD8 ratio, due to the increased number of T-suppres­
sor/cytotoxic cells. In patients with HT and hypothyroidism the main cell population con­
sisted of CD3+cells and increased number of CD16+56+ cells as the CD4/CD8 ratio was 
decreased (0,98). The presence of increased percentage ofIL-2 receptors and of adhesion 
molecules ICAM-1 in these patients suggests a more pronounced activity of the autoim­
mune process. 
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The thyroid gland is suitable 
organ for direct examinination by fine 
aspiration biopsy and thus it is an ap-
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propriated model for serial trials of un­
derlying disturbances of immune regu­
lation connected to autoimmune thyroid 
diseases and their response to corre­
sponding treatment (3). It was previ­
ously established on mononuclear cells 
of intrathyroidal materials and their 
phenotyping that most cells are T- lym-
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phocytes (1,2,4). Nevertheless the re­
ported changes of T - and B-cells in 
Basedow ' s disease ( B D ) and 
Hashimoto's thyroiditis (HT) always are 
under discussion so that similar studies 
have been carried out extremely on sur­
gical materials of patients preliminary 
treated by thionamide, levothyroxin, or 
jodide that can change the quantity and 
quality ratio of T - and B-lymphocytes 
(5,6,8). Otherwise the tests of untreated 
patients do not cover peripheral blood 
( P B ) because the changes of peripheral 
T-and B-cells can not provide a full pic­
ture of processes that take place in 
intrathyroidal ( I T ) T - and B-population 
as well as their subsets although there 
is a risk of interference with peripheral 
cells as the materials are taken by fine 
needle aspiration biopsy ( F N A B ) (7). 
In this trial we evaluate the pos­
sibility of using laser, two-colour fiow 
cytometry to define the lymphocyte sub­
sets of cells obtained by F N A in patients 
with Grave's disease (GD) and HT. The 
aim of the study is to establish the 
changes of ce l l immuni ty of 
intrathyroidal as well as peripheral 
blood in patients with B D and H T be­
fore and after treatment. 
MATERIAL AND METHODS 
Twenty-six patients with active 
B D (23 women and 3 men, mean age 
42,34 years) were studied for a period 
of 16,84 months of treatment. These 
patients were followed-up during 24 
months as they finished their Metizol 
therapy. For a 5-year period 12 patients 
with H T were studied (11 female and 1 
male) at mean age of 45,3 years. The 
patients were clinically euthyroid at the 
start of the study. Six patients at the end 
of the observation period developed hy­
pothyroidism. 
The trial comprised patient's 
histories, clinical data, hormonal lev­
els ( T S H , F T 4 and F T 3 were measured 
radioimmunologically). Microsomal 
autoantibodies (MsAb) and thyroglobu-
lin autoantibodies (TgAb) were mea­
sure by haemoagglutinaton method, the 
percentages of lymphocyte subsets in 
peripheral mononuclear blood cells 
( P M B C ) , and intrathyroidal mono­
nuclear cells ( I T M C ) were evaluated by 
flow-cytometry with monoclonal anti­
bodies - I M K Plus ki t Bec ton -
Dickinson - (CD3+ - total T-lympho-
cytes; C D 19+ - total В lymphocytes; 
CD4+ - T helper/inducer lymphocytes; 
CD8+ - T - suppressor/cytotoxic lym­
phocytes; C D 3 + / H L A - D R + - activated 
T lymphocytes; C D 16+ /56+ - natural 
killer cells; CD25+- Interleukin-2 re­
ceptors and CD54+ - adhesion molecule 
I C A M - 1 ) . Ultrasound examination by 
Aloka S S D 920 apparatus with a 7,5 
MHz sector transducer was done. I T M C 
were obtained by F N A B of the thyroid 
gland. 
RESULTS AND DISCUSSION 
Our results showed lack of any 
significant differences between lym­
phocyte subsets in peripheral blood in 
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ealthy control group and patients at 
ctive stage of B D , with exception of 
in imal differences contributing 
" D 3 + / H L A - D R + lymphocytes and 
evel of CD8+ lymphocytes with slight 
ncreased of CD4/CD8 ratio, respec-
ively. 
In contrast to peripheral lym­
phocyte markers of the IT changes were 
xpressively enhanced especially in 
patients in active B D where twice in­
creased level of C D 19+ lymphocytes 
than in controls was found. On second 
place the level of C D 3 + / H L A - D R + 
lymphocytes was increased compatibly 
to controls and in P B . Significantly 
lower was the level of CD8+ cells and 
this changed the ratio between CD4+ 
and CD8+ lymphocytes over 1,4 (estab­
lished in P B of the controls). Our re­
sults did not confirm other data that 
thyrostatic treatment could lead to in­
significant redestribution of activating 
CD4+ and CD8+ subsets and to insig­
nificant changes of C D 3 + / H L A - D R + 
lymphocytes. 
Retrospective analysis of lym­
phocyte markers in 3 patients with G D 
relapse one year past after thyreostatic 
treatment showed that there were no 
changes in the level of C D 19+ cells and 
in the ratio CD3+/CD19+ lymphocytes 
- initially 1,56:1 and after treatment 
2,0:1. No changes were found in the 
level of C D 3 + / H L A - D R + cells and in 
CD4/CD8 ratio, too. It remained higher 
because of low level of CD8+ lympho­
cytes. Our study confirmed that in the 
inactive B D there was an abnormal ra­
tio of Т-lymphocyte subsets and these 
disturbances could normalize after 
Methymazole treatment. We proved the 
possibility of using flow cytometry 
model in the examination of F N A B 
specimens of the thyroid gland in order 
to establish the disturbances of immune 
regulation not only as a proof but as un­
derlying monitoring of intrathyroidal 
immune response to thyreostatic treat­
ment. 
The main cells 4 proportion of 
P M B C in patients with H T consists ba­
sically of CD3+cells with insignificant 
differences between hypothyroid (72 ± 
1,2 % ) and euthyroid patients (72,7 ±2,1 
% ) . Such statistically insignificant dif­
ferences are noticed in C D 19+(10,6 
vs. 10,4 % ) , CD3+/HLA-DR+(9 ,6 vs. 
9,8 % ) and C D 16+/56+ (18 vs. 17,5 % ) 
cells, too. Higher CD4/CD8 ratio was 
found in hypothyroid patients (2,0) than 
in the euthyroid ones (1,6) due to in­
crease of CD4+ cells. C D 19+cells were 
statistically lower in hypothyroid pa­
tients (8,0 ±2 ,1%) vs in euthyroid ones 
(29 ±1,1 % ) . A significantly higher per­
centage of CD25+ (32 ± 2 , 1 ) , CD54+ 
(70 ± 2,3), CD16+/56 (30 ± 1,8) and 
decreasing CD4/CD8 ratio (1,2 ) in hy­
pothyroid patients was found. The 
changes of I T M C showed more 
s ign i f i can t immunological distur­
bances in HT. These changes in the hy­
pothyroid patients represented a stron­
ger cell cytotoxicity and activity of au­
toimmune response. 
I l l 
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CONCLUSIONS 
1. The proportions of 
intrathyroidal C D 19+ and CD3+/HLA-
D R + lymphocytes in patients with B D 
are significantly increased in compari­
son with P B M C of the same patients. 
2. After thyreostatic therapy 
there is normalization of C D 1 9 + , 
C D 3 + / H L A - D R + lymphocytes and re­
duction of CD4/CD8 ratio due to the 
increased number of T-suppressor/cy­
totoxic cells. 
3. There is no decrease of 
C D 19+ and C D 3 + / H L A - D R + lympho­
cytes and redistribution of CD4/CD8 
ratio in patients with B D relapse. 
4. In patients with H T and hy­
pothyroidism there is an increased num­
ber of C D 16+56+ cells, decreased CD4/ 
CD8 ratio, and increased percentage of 
IL-2 receptors and of 1С AM-1 adhesion 
molecules in comparison with euthyroid 
patients with HT. 
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Интратиреоидни лимфоцитни подкласове при болни 
с автоимунни тиреоидин заболявания 
К. Христозов, Л. Коева, С. Балев*, Ц. Оджакова* 
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Резюме: Щитовидната жлеза е лесно достъпен- орган за директни изследвания 
посредством аспирационна биопсия, което позволява серийно изучаване на 
подлежащите нарушения в имунната регулация, свързани с автоимунните тиреоидни 
заболявания и техния отговор към съответното лечение. Бяха изследвани и проследени 
26 болни с Базедова болест (ББ) и 12 - с тиреоидит на Хашимото (ТХ) - общо 34 жени 
и 4 мъже, на средна възраст 47,3 г. За определяне на повърхностните маркери на 
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интратиреоидните мононуклеарни клетки (ИТМК) бяха използвани антитела за 
идентифициране на Т-лимфоцити (CD3+), Т-хелпери (CD4+), Т-супресори (CD8+), 
В-лимфоцити (CD 19+), НК-клетки (CD16+/56), активирани Т-лимфоцити (HLA-DR+), 
рецептори за интерлевкин-2 (CD25+) и адхезионни молекули от типа ICAM-1 (CD54+). 
При болните с ББ основната лимфоцитна популация бе CD3+, с увеличен брой 
ктивирани Т-лимфоцити и повишено CD4+/CD8+ отношение (2,22), дължащо се на 
амаление на Т-супресорите. Проведеното тиреостатично лечение води до 
ормализиране на В-лимфоцитите, на активираните Т-лимфоцити и снижение на 
отношението CD4+/CD8+ за сметка на увеличението на Т-супресорите. При болните 
с ТХ и настъпил хипотиреоидизъм основната клетъчна популация също се състои от 
CD3+ клетки, както и от по-голям брой CD16+/56 клетки и намалено CD4+/CD8+ 
отношение (0,98). Наличието на увеличен процент на рецептори за интерлевкин-2 и 
адхезионни молекули от типа 1С АМ-1 при тези болни подсказва по-изразена активност 
а автоимунния процес. 
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